SEC Form 4 · accession 0001209191-15-017763
MEDASSETS INC · MDAS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Bardis
Director
Period of report
Feb 24, 2015
Accepted (ET)
Feb 24, 2015 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001254419
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 24, 2015 | S | 100,000 | $19.45 | D | 210,373 | D | |
| Common Stock | holding | — | — | — | 8,000 | I | By Spouse | |
| Restricted Stock | holding | — | — | — | 11,969 | D | ||
| Restricted Stock | holding | — | — | — | 13,256 | D | ||
| Restricted Stock | holding | — | — | — | 13,997 | D | ||
| Restricted Stock | holding | — | — | — | 30,397 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.25 to $19.75, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.